Pankaj Patel

Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial

Samer Gawrieh, Mazen Noureddin, Nicole Loo et al. · Hepatology · 2021 · 335 citations · Full text

Dual <scp>PPAR</scp>α/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental <scp>NASH</scp> models

Mukul R. Jain, Suresh Giri, Bibhuti Bhoi et al. · Liver International · 2017 · 197 citations · Full text

A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)

Vikas Pai, A Paneerselvam, Satinath Mukhopadhyay et al. · Journal of Diabetes Science and Technology · 2014 · 108 citations · Full text

Evaluation of the utility of the Ponseti method of correction of clubfoot deformity in a developing nation

Ankur Gupta, Saurabh Singh, Pankaj Patel et al. · International Orthopaedics · 2006 · 103 citations · Full text

Clubfoot Deformity, Limb Reconstruction, Kinesiology +10

Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridines

Rajesh Bahekar, Mukul R. Jain, Pradip Jadav et al. · Bioorganic & Medicinal Chemistry · 2007 · 90 citations

Medicinal Chemistry, Medicine, Antidiabetic Activity +5